181 related articles for article (PubMed ID: 8624605)
21. A very mild form of non-Herlitz junctional epidermolysis bullosa: BP180 rescue by outsplicing of mutated exon 30 coding for the COL15 domain.
Pasmooij AM; van Zalen S; Nijenhuis AM; Kloosterhuis AJ; Zuiderveen J; Jonkman MF; Pas HH
Exp Dermatol; 2004 Feb; 13(2):125-8. PubMed ID: 15009107
[TBL] [Abstract][Full Text] [Related]
22. Hemidesmosomal molecular changes in dermatitis herpetiformis; decreased expression of BP230 and plectin/HD1 in uninvolved skin.
Leivo T; Lohi J; Kariniemi AL; Molander G; Kiraly CL; Kotovirta ML; Owaribe K; Burgeson RE; Leivo I
Histochem J; 1999 Feb; 31(2):109-16. PubMed ID: 10416682
[TBL] [Abstract][Full Text] [Related]
23. Do mutations in the basement membrane zone affect the human periodontium? Review with special reference to epidermolysis bullosa.
Wiebe CB; Larjava HS
J West Soc Periodontol Periodontal Abstr; 1998; 46(1):5-18. PubMed ID: 9709672
[TBL] [Abstract][Full Text] [Related]
24. Epidermolysis bullosa: a spectrum of clinical phenotypes explained by molecular heterogeneity.
Uitto J; Pulkkinen L; McLean WH
Mol Med Today; 1997 Oct; 3(10):457-65. PubMed ID: 9358473
[TBL] [Abstract][Full Text] [Related]
25. Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone.
Has C; Nyström A; Saeidian AH; Bruckner-Tuderman L; Uitto J
Matrix Biol; 2018 Oct; 71-72():313-329. PubMed ID: 29627521
[TBL] [Abstract][Full Text] [Related]
26. Molecular organization of the basement membrane zone.
Hashmi S; Marinkovich MP
Clin Dermatol; 2011; 29(4):398-411. PubMed ID: 21679867
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathology of the cutaneous basement membrane zone.
Mellerio JE
Clin Exp Dermatol; 1999 Jan; 24(1):25-32. PubMed ID: 10233645
[TBL] [Abstract][Full Text] [Related]
28. [Hereditary bullous epidermolyses. Recent aspects of diagnosis and therapy].
Krieg T; Schurig V; Braun-Falco O
Hautarzt; 1986 Apr; 37(4):185-9. PubMed ID: 3009355
[TBL] [Abstract][Full Text] [Related]
29. A homozygous deletion mutation in the gene encoding the 180-kDa bullous pemphigoid antigen (BPAG2) in a family with generalized atrophic benign epidermolysis bullosa.
McGrath JA; Darling T; Gatalica B; Pohla-Gubo G; Hintner H; Christiano AM; Yancey K; Uitto J
J Invest Dermatol; 1996 Apr; 106(4):771-4. PubMed ID: 8618019
[TBL] [Abstract][Full Text] [Related]
30. 180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa.
Jonkman MF; de Jong MC; Heeres K; Pas HH; van der Meer JB; Owaribe K; Martinez de Velasco AM; Niessen CM; Sonnenberg A
J Clin Invest; 1995 Mar; 95(3):1345-52. PubMed ID: 7883981
[TBL] [Abstract][Full Text] [Related]
31. Premature termination codons are present on both alleles of the bullous pemphigoid antigen 2/type XVII collagen gene in five Austrian families with generalized atrophic benign epidermolysis bullosa.
Darling TN; McGrath JA; Yee C; Gatalica B; Hametner R; Bauer JW; Pohla-Gubo G; Christiano AM; Uitto J; Hintner H; Yancey KB
J Invest Dermatol; 1997 Apr; 108(4):463-8. PubMed ID: 9077475
[TBL] [Abstract][Full Text] [Related]
32. Using immunofluorescence (antigen) mapping in the diagnosis and classification of epidermolysis bullosa: a first report from Iran.
Barzegar M; Asadi-Kani Z; Mozafari N; Vahidnezhad H; Kariminejad A; Toossi P
Int J Dermatol; 2015 Oct; 54(10):e416-23. PubMed ID: 26220012
[TBL] [Abstract][Full Text] [Related]
33. Defining target antigens in linear IgA disease using skin from subjects with inherited epidermolysis bullosa as a substrate for indirect immunofluorescence microscopy.
Harman KE; Bhogal BS; Eady RA; McGrath JA; Black MM
Br J Dermatol; 1999 Sep; 141(3):475-80. PubMed ID: 10583051
[TBL] [Abstract][Full Text] [Related]
34. A founder COL17A1 splice site mutation leading to generalized atrophic benign epidermolysis bullosa in an extended inbred Palestinian family from Israel.
Whittock NV; Sher C; Gold I; Libman V; Reish O
Genet Med; 2003; 5(6):435-9. PubMed ID: 14614394
[TBL] [Abstract][Full Text] [Related]
35. Prognostic implications of determining 180 kDa bullous pemphigoid antigen (BPAG2) gene/protein pathology in neonatal junctional epidermolysis bullosa.
Mellerio JE; Denyer JE; Atherton DJ; Eady RA; McGrath JA
Br J Dermatol; 1998 Apr; 138(4):661-6. PubMed ID: 9640376
[TBL] [Abstract][Full Text] [Related]
36. Three new cases of transient bullous dermolysis of the newborn.
Hanson SG; Fine JD; Levy ML
J Am Acad Dermatol; 1999 Mar; 40(3):471-6. PubMed ID: 10071321
[TBL] [Abstract][Full Text] [Related]
37. Plectin and human genetic disorders of the skin and muscle. The paradigm of epidermolysis bullosa with muscular dystrophy.
Uitto J; Pulkkinen L; Smith FJ; McLean WH
Exp Dermatol; 1996 Oct; 5(5):237-46. PubMed ID: 8981021
[TBL] [Abstract][Full Text] [Related]
38. Novel ITGB4 mutations in a patient with junctional epidermolysis bullosa-pyloric atresia syndrome and altered basement membrane zone immunofluorescence for the alpha6beta4 integrin.
Takizawa Y; Shimizu H; Nishikawa T; Hatta N; Pulkkinen L; Uitto J
J Invest Dermatol; 1997 Jun; 108(6):943-6. PubMed ID: 9182827
[TBL] [Abstract][Full Text] [Related]
39. Cycloheximide facilitates the identification of aberrant transcripts resulting from a novel splice-site mutation in COL17A1 in a patient with generalized atrophic benign epidermolysis bullosa.
Darling TN; Yee C; Koh B; McGrath JA; Bauer JW; Uitto J; Hintner H; Yancey KB
J Invest Dermatol; 1998 Feb; 110(2):165-9. PubMed ID: 9457913
[TBL] [Abstract][Full Text] [Related]
40. Decreased mRNA expression of several basement membrane components in basal cell carcinoma.
Chopra A; Maitra B; Korman NJ
J Invest Dermatol; 1998 Jan; 110(1):52-6. PubMed ID: 9424087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
